Indian Pharma Sector’s Growth Prospects in 2024
Indian Pharmaceutical Sector: A Promising Outlook for 2024 The Indian pharmaceutical sector is experiencing a significant upswing, propelled by a
Read More
Medical
Vibrating weight loss pill could provide alternative to Ozempic and Wegovy, say researchers
A vibrating pill has shown promise in early studies as a possible obesity treatment. Developed by engineers at MIT (Massachusetts
Read More
Rural Missouri has very few doctors. MU hopes to change that | Higher Education
For years, health care in rural Missouri has been spotty and insufficient. University of Missouri’s School of Medicine is hoping
Read More
Newsmaker | ‘Upgrade Quality or Risk Shutdowns’: How India’s New DCGI is Rebuilding ‘Pharmacy of the World’
India’s pharmaceutical industry has undergone a comprehensive regulatory overhaul spearheaded by the nation’s apex health regulatory agency and its chief,
Read More
Why GSK’s Flovent asthma inhaler is being discontinued in 2024 : Shots
Doctors and medical societies are suggesting patients who rely on Flovent take action now to ensure they can get the
Read More
Why Doctor Refused to Help in Mid-Air Emergency on Long-Haul Flight Backed
A medical doctor has received support online after sharing that he had refused to help a passenger in need of
Read More
In 2024, India’s pharma market is poised for further evolution, transformative shifts, ET HealthWorld
Mumbai: As the nation is gearing up to welcome the new year 2024, the Indian pharma sector in 2023 traversed
Read More
New weight loss drugs out of reach for many in U.S. | Front Page
WASHINGTON (AP) — New obesity drugs are showing promising results in helping some people shed pounds but the injections will
Read More
Doctors seek another revision of the NEET SS cut-off, mop-up round to fill vacant seats in super speciality courses
Image used for representation purpose only. The United Doctors Front Association (UDFA) wrote to the Health Ministry on December 29,
Read More "Investments worth Rs 25,813 cr made under pharma PLI as of Sep: Govt")
Investments worth Rs 25,813 cr made under pharma PLI as of Sep: Govt
The total outlay of the scheme is Rs 15,000 crore and the scheme duration is from 2020-2021 to 2028-29, an
Read More